Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition

BACKGROUND: Frailty and dementia have a bidirectional relationship. However, frailty is rarely reported in clinical trials for dementia and mild cognitive impairment (MCI) which limits assessment of trial applicability. This study aimed to use a frailty index (FI)—a cumulative deficit model of frail...

Descripción completa

Detalles Bibliográficos
Autores principales: Wightman, Heather, Quinn, Terry J., Mair, Frances S., Lewsey, Jim, McAllister, David A., Hanlon, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262528/
https://www.ncbi.nlm.nih.gov/pubmed/37312157
http://dx.doi.org/10.1186/s13195-023-01260-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262528/
https://www.ncbi.nlm.nih.gov/pubmed/37312157
http://dx.doi.org/10.1186/s13195-023-01260-3

Ejemplares similares